Based on the Ayala Pharmaceuticals Inc. stock forecast from 0 analysts, the average analyst target price for Ayala Pharmaceuticals Inc. is not available over the next 12 months. Ayala Pharmaceuticals Inc. ’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Ayala Pharmaceuticals Inc. is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Ayala Pharmaceuticals Inc. ’s stock price was USD 0.03. Ayala Pharmaceuticals Inc. ’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -95.71% over the last year.
No recent analyst target price found for Ayala Pharmaceuticals Inc.
No recent average analyst rating found for Ayala Pharmaceuticals Inc.
Company Overview Ayala Pharmaceuticals Inc.
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware. Read Less
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma ...Read More
Frequently Asked Questions About Ayala Pharmaceuticals Inc. (ADXS) Stock
Stock Target Advisor's fundamental analysis for Ayala Pharmaceuticals Inc. 's stock is Very Bearish.
Unfortunately we do not have enough data on ADXS's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ADXS's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ADXS's stock to indicate if its overvalued.
The last closing price of ADXS's stock was USD 0.03.
The most recent market capitalization for ADXS is USD 1.15M.
Unfortunately we do not have enough analyst data on ADXS's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Ayala Pharmaceuticals Inc. 's stock.
As per our most recent records Ayala Pharmaceuticals Inc. has 20 Employees.
Ayala Pharmaceuticals Inc. 's registered address is 1007 North Orange Street, Wilmington, DE, United States, 19802.
You can get more information about it from Ayala Pharmaceuticals Inc. 's website at https://www.ayalapharma.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About Ayala Pharmaceuticals Inc. (ADXS) Stock
Stock Target Advisor's fundamental analysis for Ayala Pharmaceuticals Inc. 's stock is Very Bearish.
Unfortunately we do not have enough data on ADXS's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ADXS's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ADXS's stock to indicate if its overvalued.
The last closing price of ADXS's stock was USD 0.03.
The most recent market capitalization for ADXS is USD 1.15M.
Unfortunately we do not have enough analyst data on ADXS's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Ayala Pharmaceuticals Inc. 's stock.
As per our most recent records Ayala Pharmaceuticals Inc. has 20 Employees.
Ayala Pharmaceuticals Inc. 's registered address is 1007 North Orange Street, Wilmington, DE, United States, 19802.
You can get more information about it from Ayala Pharmaceuticals Inc. 's website at https://www.ayalapharma.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ADXS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
